Research from Alex Kwan’s lab has suggested that dendritic plasticity may help support the idea that ketamine and psilocybin can help individuals adopt new perspectives and better process new experiences.
What is the environmental cost of industrial cannabis cultivation? And how can it be paid back? Alisia and Christopher Ratliff of Victus Capital talk the future of cannabis sustainability.
Analytical Cannabis speaks to Keith Browning, CEO of Method Testing Labs, about the company's use of lean processing and the benefits its brought.
There are two main methods for detecting microbes in cannabis samples, plating and DNA/RNA tests, and they both have their challenges, writes Yan Shipelskiy, lab director of Green Scientific Labs.
How can in vitro plant propagation techniques benefit a cannabis cultivation business? Dr Veronica Codesido, manager of breeding and cultivation at MIFCO Biosciences, explained all at the Analytical Cannabis Expo Europe Online 2021.
Unsure of which grow lights to buy? Analytical Cannabis spoke to the experts to find out the different types of lights available, what key factors to consider, and the recent advancements in the field.
Technology Networks spoke to the co-founder of Field Trip Health, a Toronto-based provider of ketamine therapy, on why 2021 was such a significant year for psychedelics.
To discuss the chromatographic challenges posed by novel cannabinoids, Analytical Cannabis recently spoke with Sean Orlowicz, business development manager for food and cannabis at Phenomenex.
To date, no classical psychedelic agents have been approved for use as a medicine but what does convention tell us about the way these drugs will be scrutinized and assessed for quality?